A A A
Click to change text size

Philadelphia Personal Injury Attorney Blog | Pomerantz Perlberger & Lewis LLP

Philadelphia Personal Injury and Medical Malpractice Attorneys serving the Philadelphia and Pennsylvania areas. Pomerantz, Perlberger and Lewis have extensive experience with serious injuries as a result of someone else's negligence.

Tuesday, December 4, 2007

Avandia in the News Again, This Time for Causing Bone Fractures

The popular diabetes drug Avandia (generic rosiglitazone), in addition to causing serious heart risks, may also increase bone thinning, a discovery that could help explain why diabetics can have an increased risk of fractures.

New research raises the possibility that long-term use of this drug could lead to osteoporosis. Researchers have found that in mice, the drug increased the activity of cells that degrade bones, according to information published in this week’s online issue of Nature Medicine.

Avandia was recently in the news again when it was labeled with a second black box warning for its risk of heart failure in some patients. GlaxoSmithKline, manufacturer of Avandia, has already acknowledged that a study found a higher risk of fractures among women who take the drug.

If you or a loved one has been harmed by a defective drug or some other defective product in Philadelphia, please contact the product liability attorneys at Pomerantz Perlberger & Lewis today to schedule your initial consultation.

posted by Lynn at 9:18:00 AM

0Comments:

Post a Comment

<< Home